Program Manager

Carbapenemase-producing Enterobacterales are a growing antimicrobial resistance threat in Australia. The $3.9 million STOP-CPE program unites eleven Chief Investigators, nine institutions and clinical sites across four states, with this part-time role supporting its delivery.